Studies of KRASMut lung cancer models reveal that prolonged antioxidant administration (N-acetylcysteine and vitamin E) promotes metastatic progression by reducing intracellular heme availability, which subsequently stabilizes the BACH1 transcription factor. Here, BACH1 is linked to lung cancer.